Trump 2019: Three Things To Expect in Health Care
Client Alert | less than 1 min read | 12.12.18
As part of our Trump 2019: What To Expect series, Traci Vitek, senior policy director with the firm, and Jerrica Mathis, director in Crowell & Moring’s Government Affairs Group, sit down to discuss what we can expect Congress and the White House to focus on in 2019 regarding health care.
Discussed in this 24-minute podcast:
- Health care plans and how they are marketed.
- Drug pricing proposals.
- Congressional oversight.
Click below to listen or access from one of these links:
PodBean | SoundCloud | iTunes
Insights
Client Alert | 5 min read | 04.13.26
EU Pharma Package: Global (Orphan) Marketing Authorization Compromise Proposal
In our fifth alert in this EU Pharma Package Series, we provided an analysis of the background and ongoing legal debates regarding the concept of the global marketing authorization (GMA). We discussed in particular the missed opportunities in the Pharma Package to further codify and clarify the GMA, in view of its central role in determining the regulatory data protection (RDP) rights of a medicinal product.
Client Alert | 4 min read | 04.13.26
Client Alert | 4 min read | 04.10.26
CMS Finalizes Rate Notice for Medicare Parts C and D (CY 2027)
Client Alert | 2 min read | 04.10.26
